How does one assess early rheumatoid arthritis in daily clinical practice?
about
DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment.Beta-defensin-2 protein is a serum biomarker for disease activity in psoriasis and reaches biologically relevant concentrations in lesional skinSubcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience.Homeopathy has clinical benefits in rheumatoid arthritis patients that are attributable to the consultation process but not the homeopathic remedy: a randomized controlled clinical trial.Factors predicting the outcome of customised foot orthoses in patients with rheumatoid arthritis: a prospective cohort study.Baseline factors predicting change from the initial DMARD treatment during the first 2 years of rheumatoid arthritis: experience in the ERAN inception cohort.Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis.Association of single nucleotide polymorphism at position -308 of the tumor necrosis factor-alpha gene with ankylosing spondylitis and rheumatoid arthritis.Measures of rheumatoid arthritis disease activity in Australian clinical practiceChanging clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies.Predictors of change in bodily pain in early rheumatoid arthritis: an inception cohort studyRisk factors for falls in adults with rheumatoid arthritis: a prospective study.Work disability and state benefit claims in early rheumatoid arthritis: the ERAN cohort.Enhanced liver fibrosis test in patients with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional comparison with procollagen-3 N-terminal peptide (P3NP).TIM-1 rs41297579 G>A (-1454) and TIM-4 rs7700944 gene polymorphisms as possible risk factor for rheumatoid arthritis: relation to activity and severity.Illness perceptions account for variation in positive outlook as well as psychological distress in rheumatoid arthritis.Negative and positive illness representations of rheumatoid arthritis: a latent profile analysis.Methodological issues in the design of a rheumatoid arthritis activity score and its cut-offs.Inter- and intra-observer agreement of high-resolution ultrasonography and power Doppler in assessment of joint inflammation and bone erosions in patients with rheumatoid arthritis.Erosive and osteoarthritic structural progression in early rheumatoid arthritis.Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis.Functional FCGR3A 158 V/F and IL-6 −174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis
P2860
Q24812386-21DA1BBA-4D2E-4028-8BDC-11D938C65CDAQ33415491-DC02F8E7-CCA5-44BF-B65E-E4A794E2ABBAQ34036038-86A65B48-FF87-49AB-8EA0-F5995FCB9A39Q34149748-3E048CE4-11F2-48A1-B406-FF8DB9B8B8C5Q34633421-685DDE45-23EE-45CE-B0ED-A42D96652CFDQ34698789-CEB983D7-73F5-4913-AB24-25AAD1115259Q35553389-39B1592C-0C4C-4356-8149-08373BDE448EQ35614010-6D83B336-BE6A-49E1-BD87-6C44E1466779Q35687818-C76D19A6-8840-4FC8-B516-DB3F3927327CQ35906327-AFBC6010-A184-4E55-8954-AB2C812CE553Q37165244-764055EB-16CE-4629-BA3E-519F65D4CFA0Q37436445-42B66754-2ED0-4843-A85B-FA5490BC19F6Q37595991-20196E01-CC31-4450-8331-B2EFB7E046A9Q39124718-CF9501FB-3F64-4F8B-9A44-BB144B8CD458Q39272815-0D58DFB8-66A4-4D10-B527-CB13E34DA5FCQ39683648-D4E8DD17-81D0-45C3-B6D5-52A60EF26811Q42694478-16D9E061-C52D-4429-B7B9-F73E05F040A6Q42734608-B99A37FA-F360-455F-96BF-832A20D68A1EQ46190009-39D052E9-7393-4508-BBA9-7BBAF99A5EFDQ48034970-D6B03333-868D-4F7B-B59D-318557B055E9Q53393095-48781B51-F865-4295-A501-E05BDA052ECAQ57330337-3BA48306-74AF-4743-8F56-335873FDF634
P2860
How does one assess early rheumatoid arthritis in daily clinical practice?
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
How does one assess early rheumatoid arthritis in daily clinical practice?
@ast
How does one assess early rheumatoid arthritis in daily clinical practice?
@en
How does one assess early rheumatoid arthritis in daily clinical practice?
@nl
type
label
How does one assess early rheumatoid arthritis in daily clinical practice?
@ast
How does one assess early rheumatoid arthritis in daily clinical practice?
@en
How does one assess early rheumatoid arthritis in daily clinical practice?
@nl
prefLabel
How does one assess early rheumatoid arthritis in daily clinical practice?
@ast
How does one assess early rheumatoid arthritis in daily clinical practice?
@en
How does one assess early rheumatoid arthritis in daily clinical practice?
@nl
P356
P1476
How does one assess early rheumatoid arthritis in daily clinical practice?
@en
P2093
Schumacher HR Jr
van Riel PL
P356
10.1053/BERH.2000.0126
P577
2001-03-01T00:00:00Z